Final Exam Test Questio
bn bn bn
ns
1.Question 18: bn
Christine is a 9-year- bn bn bn
old female who presents for care after having been placed in the local fos
bn bn bn bn bn bn bn bn bn bn bn bn bn
ter care system. She has been in and out of foster care for the last 4 ye
bn bn bn bn bn bn bn bn bn bn bn bn bn bn bn bn
ars after her parents were killed in an automobile accident. Christine has
bn bn bn bn bn bn bn bn bn bn bn
bnbeen placed in a variety of homes and residential care facilities. The P
bn bn bn bn bn bn bn bn bn bn bn bn
MHNP recognizes that Christine is at high risk for:: A. Dissociative disor
bn bn bn bn bn bn bn bn bn bn bn
ders
B. Post-traumatic stress disorder
bn bn bn
C. Impulse-control disorder
bn bn
D. Attachment disorder
bn bn
2.Question 7: bn
Caylee is a 5-year- bn bn bn
old girl who is referred for evaluation by child protective services. She
bn bn bn bn bn bn bn bn bn bn bn bn
was recently removed from her biological family and placed in foster car
bn bn bn bn bn bn bn bn bn bn bn
e, as her home environment was reportedly unsafe due to conditions of e
bn bn bn bn bn bn bn bn bn bn bn bn
xtreme neglect. Her foster mother reports that Caylee is very quiet and
bn bn bn bn bn bn bn bn bn bn bn bn
withdrawn and always appears sad and disinterested in her surrounding
bn bn bn bn bn bn bn bn bn
s; however, she becomes very irritable when anything unexpected or unpl
bn bn bn bn bn bn bn bn bn bn
anned occurs. The foster mother became very concerned when it appear
bn bn bn bn bn bn bn bn bn bn
ed that Caylee was hallucinating. The PMHNP considers that:: A. Caylee
bn bn bn bn bn bn bn bn bn bn b
nis at high risk for suicide and precautions should be taken
bn bn bn bn bn bn bn bn bn bn
B. The hallucinations are consistent with brief psychotic disorder or sc
bn bn bn bn bn bn bn bn bn bn
izophrenia
C. The history and reported symptoms are typical of depressive disor
bn bn bn bn bn bn bn bn bn bn
der in young children
bn bn bn
D. This is a common situation when prepubertal children are removed
bn bn bn bn bn bn bn bn bn bn
bnfrom the biological parents regardless of how dysfunctional they are
bn bn bn bn bn bn bn bn bn
3.Question 2: bn
Debi is a 15-year- bn bn bn
old girl who is currently being treated for depression. Her parents have
bn bn bn bn bn bn bn bn bn bn bn bn
been very proactive and involved in her care, and Debi has achieved re
bn bn bn bn bn bn bn bn bn bn bn bn
mission 2 months after beginning treatment with a combination of pharm
bn bn bn bn bn bn bn bn bn bn
acotherapy and cognitive behavioral therapy. While counseling Debi's par
bn bn bn bn bn bn bn bn
ents about important issues in management, the PMHNP advises that:: A
bn bn bn bn bn bn bn bn bn bn
. There is a > 50% likelihood that Debi's younger sibling will develop
bn bn bn bn bn bn bn bn bn bn bn bn
bndepressive symptoms bn
B. The mean length of major depressive episode in adolescents is 4 m
bn bn bn bn bn bn bn bn bn bn bn bn
onths
C. 20 to 40% of adolescents who have major depressive disorder will d
bn bn bn bn bn bn bn bn bn bn bn bn
1bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
evelop bipolar I within 5 years
bn bn bn bn bn
D. Adolescent-onset depression typically need long-
bn bn bn bn bn
term pharmacologic manage- ment to prevent relapses
bn bn bn bn bn bn
4.Agomelatine: Brand: Valdoxan
bn bn
-Melatonin multimodal (Mel-MM)
bn bn
2bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
-Agonist at melatonergic 1 and melatonergic 2 receptors
bn bn bn bn bn bn bn
-Antagonist at 5HT2C receptors bn bn bn
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
bn bn bn bn bn bn bn bn
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/
bn bn bn bn bn bn bn bn bn bn bn bn
day at bedtime
bn bn
5.Amitriptyline (Elavil): Tricyclic antidepressant. bn bn bn
6.Aripiprazole (Abilify): Treatment for depression. Atypical antipsychoti
bn bn bn bn bn bn
c. "Dopamine stabilizer". Dopamine receptor antagonist in high conce
bn bn bn bn bn bn bn bn
ntration and also stimulates increase of dopamine in low concentratio
bn bn bn bn bn bn bn bn bn
ns. Side effects: insomnia, akathisia.
bn bn bn bn
7.Brexpiprazole (Rexulti): Treatment for depression. Atypical antipsycho
bn bn bn bn bn bn
c
8.Bupropion (Wellbutrin): Antidepressant and smoking cessation aid, It
bn bn bn bn bn bn bn b
ncan treat depression and help people quit smoking. It can also preve
bn bn bn bn bn bn bn bn bn bn bn
nt depression caused by seasonal affective disorder (SAD).
bn bn bn bn bn bn bn
9.Citalopram (Celexa): Antidepressant, SSRI: 20-40 mg qd.
bn bn bn bn bn bn
10.Clomipramine (Anafranil): -Serotonin reuptake inhibitor (S-RI) bn bn bn bn bn
-Tricyclic antidepressant (TCA) bn bn
-Parent drug is a potent serotonin reuptake inhibitor
bn bn bn bn bn bn bn
Active metabolite is a potent norepinephrine/
bn bn bn bn bn
noradrenaline reuptake inhibitor bn bn
-
Increases serotonergic neurotransmission by blocking the serotonin reu
bn bn bn bn bn bn bn
ptake pump (transporter), -
bn bn bn
Desensitization of serotonin receptors, especially serotonin 1A recep-
bn bn bn bn bn bn bn
bntors
-
Increases noradrenergic neurotransmission by blocking the norepinep
bn bn bn bn bn bn
hrine reup- take pump (transporter), -
bn bn bn bn bn
Desensitization of beta adrenergic receptors bn bn bn bn
-
Dopamine is inactivated by norepinephrine reuptake in the frontal cor
bn bn bn bn bn bn bn bn bn
ex
-Lacks dopamine transporters
bn bn
-Increases dopamine neurotransmission in this part of the brain
bn bn bn bn bn bn bn bn
**FDA Approved for Pediatrics in tx Obsessive-
bn bn bn bn bn bn
compulsive disorder (OCD) (ages 10 and older) bn bn bn bn bn bn
*Off-Label for Pediatric Use: Depression, Severe and treatment-
bn bn bn bn bn bn bn
resistant, depres- sion, Cataplexy syndrome, Anxiety, Insomnia,
bn bn bn bn bn bn
3bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
Neuropathic pain/chronic pain bn bn
-Full therapeutic benefits may take 2-8 weeks
bn bn bn bn bn bn
-Dosing: in Peds/Adolescents/Adults:
bn bn
100-250mg/day
11.Cyamemazine (Tercian): Treatment for depression.
bn bn bn bn
-Known as cyamepromazine bn bn
-Typical antipsychotic drug of the phenothiazine class.
bn bn bn bn bn bn
-
Treatment for schizophreni bn bn
a and psychosis-
bn bn
associated
4bn/
bn55
bn bn bn
ns
1.Question 18: bn
Christine is a 9-year- bn bn bn
old female who presents for care after having been placed in the local fos
bn bn bn bn bn bn bn bn bn bn bn bn bn
ter care system. She has been in and out of foster care for the last 4 ye
bn bn bn bn bn bn bn bn bn bn bn bn bn bn bn bn
ars after her parents were killed in an automobile accident. Christine has
bn bn bn bn bn bn bn bn bn bn bn
bnbeen placed in a variety of homes and residential care facilities. The P
bn bn bn bn bn bn bn bn bn bn bn bn
MHNP recognizes that Christine is at high risk for:: A. Dissociative disor
bn bn bn bn bn bn bn bn bn bn bn
ders
B. Post-traumatic stress disorder
bn bn bn
C. Impulse-control disorder
bn bn
D. Attachment disorder
bn bn
2.Question 7: bn
Caylee is a 5-year- bn bn bn
old girl who is referred for evaluation by child protective services. She
bn bn bn bn bn bn bn bn bn bn bn bn
was recently removed from her biological family and placed in foster car
bn bn bn bn bn bn bn bn bn bn bn
e, as her home environment was reportedly unsafe due to conditions of e
bn bn bn bn bn bn bn bn bn bn bn bn
xtreme neglect. Her foster mother reports that Caylee is very quiet and
bn bn bn bn bn bn bn bn bn bn bn bn
withdrawn and always appears sad and disinterested in her surrounding
bn bn bn bn bn bn bn bn bn
s; however, she becomes very irritable when anything unexpected or unpl
bn bn bn bn bn bn bn bn bn bn
anned occurs. The foster mother became very concerned when it appear
bn bn bn bn bn bn bn bn bn bn
ed that Caylee was hallucinating. The PMHNP considers that:: A. Caylee
bn bn bn bn bn bn bn bn bn bn b
nis at high risk for suicide and precautions should be taken
bn bn bn bn bn bn bn bn bn bn
B. The hallucinations are consistent with brief psychotic disorder or sc
bn bn bn bn bn bn bn bn bn bn
izophrenia
C. The history and reported symptoms are typical of depressive disor
bn bn bn bn bn bn bn bn bn bn
der in young children
bn bn bn
D. This is a common situation when prepubertal children are removed
bn bn bn bn bn bn bn bn bn bn
bnfrom the biological parents regardless of how dysfunctional they are
bn bn bn bn bn bn bn bn bn
3.Question 2: bn
Debi is a 15-year- bn bn bn
old girl who is currently being treated for depression. Her parents have
bn bn bn bn bn bn bn bn bn bn bn bn
been very proactive and involved in her care, and Debi has achieved re
bn bn bn bn bn bn bn bn bn bn bn bn
mission 2 months after beginning treatment with a combination of pharm
bn bn bn bn bn bn bn bn bn bn
acotherapy and cognitive behavioral therapy. While counseling Debi's par
bn bn bn bn bn bn bn bn
ents about important issues in management, the PMHNP advises that:: A
bn bn bn bn bn bn bn bn bn bn
. There is a > 50% likelihood that Debi's younger sibling will develop
bn bn bn bn bn bn bn bn bn bn bn bn
bndepressive symptoms bn
B. The mean length of major depressive episode in adolescents is 4 m
bn bn bn bn bn bn bn bn bn bn bn bn
onths
C. 20 to 40% of adolescents who have major depressive disorder will d
bn bn bn bn bn bn bn bn bn bn bn bn
1bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
evelop bipolar I within 5 years
bn bn bn bn bn
D. Adolescent-onset depression typically need long-
bn bn bn bn bn
term pharmacologic manage- ment to prevent relapses
bn bn bn bn bn bn
4.Agomelatine: Brand: Valdoxan
bn bn
-Melatonin multimodal (Mel-MM)
bn bn
2bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
-Agonist at melatonergic 1 and melatonergic 2 receptors
bn bn bn bn bn bn bn
-Antagonist at 5HT2C receptors bn bn bn
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
bn bn bn bn bn bn bn bn
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/
bn bn bn bn bn bn bn bn bn bn bn bn
day at bedtime
bn bn
5.Amitriptyline (Elavil): Tricyclic antidepressant. bn bn bn
6.Aripiprazole (Abilify): Treatment for depression. Atypical antipsychoti
bn bn bn bn bn bn
c. "Dopamine stabilizer". Dopamine receptor antagonist in high conce
bn bn bn bn bn bn bn bn
ntration and also stimulates increase of dopamine in low concentratio
bn bn bn bn bn bn bn bn bn
ns. Side effects: insomnia, akathisia.
bn bn bn bn
7.Brexpiprazole (Rexulti): Treatment for depression. Atypical antipsycho
bn bn bn bn bn bn
c
8.Bupropion (Wellbutrin): Antidepressant and smoking cessation aid, It
bn bn bn bn bn bn bn b
ncan treat depression and help people quit smoking. It can also preve
bn bn bn bn bn bn bn bn bn bn bn
nt depression caused by seasonal affective disorder (SAD).
bn bn bn bn bn bn bn
9.Citalopram (Celexa): Antidepressant, SSRI: 20-40 mg qd.
bn bn bn bn bn bn
10.Clomipramine (Anafranil): -Serotonin reuptake inhibitor (S-RI) bn bn bn bn bn
-Tricyclic antidepressant (TCA) bn bn
-Parent drug is a potent serotonin reuptake inhibitor
bn bn bn bn bn bn bn
Active metabolite is a potent norepinephrine/
bn bn bn bn bn
noradrenaline reuptake inhibitor bn bn
-
Increases serotonergic neurotransmission by blocking the serotonin reu
bn bn bn bn bn bn bn
ptake pump (transporter), -
bn bn bn
Desensitization of serotonin receptors, especially serotonin 1A recep-
bn bn bn bn bn bn bn
bntors
-
Increases noradrenergic neurotransmission by blocking the norepinep
bn bn bn bn bn bn
hrine reup- take pump (transporter), -
bn bn bn bn bn
Desensitization of beta adrenergic receptors bn bn bn bn
-
Dopamine is inactivated by norepinephrine reuptake in the frontal cor
bn bn bn bn bn bn bn bn bn
ex
-Lacks dopamine transporters
bn bn
-Increases dopamine neurotransmission in this part of the brain
bn bn bn bn bn bn bn bn
**FDA Approved for Pediatrics in tx Obsessive-
bn bn bn bn bn bn
compulsive disorder (OCD) (ages 10 and older) bn bn bn bn bn bn
*Off-Label for Pediatric Use: Depression, Severe and treatment-
bn bn bn bn bn bn bn
resistant, depres- sion, Cataplexy syndrome, Anxiety, Insomnia,
bn bn bn bn bn bn
3bn/
bn55
, Final Exam Test Questio
bn bn bn
ns
Neuropathic pain/chronic pain bn bn
-Full therapeutic benefits may take 2-8 weeks
bn bn bn bn bn bn
-Dosing: in Peds/Adolescents/Adults:
bn bn
100-250mg/day
11.Cyamemazine (Tercian): Treatment for depression.
bn bn bn bn
-Known as cyamepromazine bn bn
-Typical antipsychotic drug of the phenothiazine class.
bn bn bn bn bn bn
-
Treatment for schizophreni bn bn
a and psychosis-
bn bn
associated
4bn/
bn55